Approval · Notice of Compliance 11129 · 2010
EMEND: Notice of Compliance 11129
Issued March 9, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11129
- Date
- March 9, 2010
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: Prevention of nausea and vomiting in women due to treatment with moderately emetogenic cancer chemotherapy
- Therapeutic class
- Neurokinin 1 (NK1) receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMEND | Not yet assigned | — |
Medicinal ingredients
- APREPITANT 80 MG per CAP
- APREPITANT 125 MG per CAP